| __timestamp | MorphoSys AG | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 9689000 | 5078000000 |
| Thursday, January 1, 2015 | 10431000 | 4717000000 |
| Friday, January 1, 2016 | 9618000 | 5096000000 |
| Sunday, January 1, 2017 | 12348000 | 4986000000 |
| Monday, January 1, 2018 | 28310241 | 4214000000 |
| Tuesday, January 1, 2019 | 59336147 | 3806000000 |
| Wednesday, January 1, 2020 | 159145941 | 3671000000 |
| Friday, January 1, 2021 | 199800000 | 3528000000 |
| Saturday, January 1, 2022 | 90225000 | 3445000000 |
| Sunday, January 1, 2023 | 92538000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. Over the past decade, Teva Pharmaceutical Industries Limited and MorphoSys AG have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. Teva, a global leader, has seen its SG&A costs decrease by approximately 31% from 2014 to 2023, reflecting strategic cost management amidst market challenges. In contrast, MorphoSys AG, a biotech innovator, experienced a staggering 857% increase in SG&A expenses during the same period, highlighting its aggressive expansion and investment in innovation. This divergence underscores the distinct paths these companies are taking: Teva's focus on efficiency and MorphoSys's commitment to growth. As the industry continues to face regulatory and competitive pressures, these financial strategies will play a pivotal role in shaping their futures.
Selling, General, and Administrative Costs: Novo Nordisk A/S vs Teva Pharmaceutical Industries Limited
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Teva Pharmaceutical Industries Limited
Takeda Pharmaceutical Company Limited and MorphoSys AG: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Teva Pharmaceutical Industries Limited and Incyte Corporation
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Madrigal Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Teva Pharmaceutical Industries Limited and Exelixis, Inc.
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Comparing Cost of Revenue Efficiency: Teva Pharmaceutical Industries Limited vs MorphoSys AG
SG&A Efficiency Analysis: Comparing Alpine Immune Sciences, Inc. and MorphoSys AG
SG&A Efficiency Analysis: Comparing Viking Therapeutics, Inc. and MorphoSys AG
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and MorphoSys AG
Comparing SG&A Expenses: MorphoSys AG vs Ligand Pharmaceuticals Incorporated Trends and Insights